Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

Mylan, Momenta take aim at Regeneron’s Eylea with biosimilar
Drug Delivery Business News
Thu, 01/4/18 - 11:01 am
Tags:
Mylan Labs, Momenta Pharmaceuticals, Regeneron, Eylea, biosimilars, diabetic macular edema, wet age-related macular degeneration, M710
On a new deal spree, Regeneron buys into ISA in pursuit of a checkpoint combo
Endpoints
Mon, 12/18/17 - 10:18 am
Tags:
Regeneron, ISA, cervical cancer, head and neck cancer, cemiplimab
Will This Drug Kick-Start Regeneron Pharmaceuticals Shares?
Motley Fool
Wed, 12/13/17 - 11:01 pm
Tags:
Regeneron, Sanofi, cemiplimab, skin cancer
Regeneron, Sanofi are ready to debut the 6th PD-1/L1. Is it still possible to stand out from the growing crowd?
Endpoints
Wed, 12/13/17 - 09:44 am
Tags:
Regeneron, Sanofi, anti-PD-L1, cemiplimab, advanced cutaneous squamous cell carcinoma
Regeneron CEO Schleifer, a year after public Pfizer spat, slams Allergan for tribal deal
Fierce Pharma
Fri, 12/1/17 - 12:39 pm
Tags:
Regeneron, Allergan, Pharma CEOs, Leonard Schleifer, Pfizer, patents, Restasis
Regeneron and Decibel aren’t just collaborating: They want to create a whole new partnering model
Endpoints
Wed, 11/29/17 - 09:57 pm
Tags:
Regeneron, Decibel Therapeutics, R&D
With Novartis closing in, Regeneron scraps Eylea combo drug in a major setback
Endpoints
Mon, 11/27/17 - 09:18 am
Tags:
Novartis, Regeneron, Eylea, RTH258, nesvacumab, Bayer
Novartis outlines its full case on why RTH258 can carve out a big piece of the AMD market held by Regeneron
Endpoints
Fri, 11/10/17 - 10:23 pm
Tags:
Novartis, RTH258, wet age-related macular degeneration, Regeneron
Drugmaker Regeneron's quarterly profit surges 47 pct
Reuters
Thu, 11/9/17 - 12:00 pm
Tags:
Regeneron, earnings
Regeneron plunks down $100M more on Ireland plant, adding another 300 workers
Fierce Pharma
Thu, 10/26/17 - 09:24 am
Tags:
Regeneron, Ireland, drug manufacturing
Sanofi’s Kevzara Could Be Solid Addition to Rheumatoid Arthritis
Market Realist
Mon, 10/16/17 - 10:27 am
Tags:
Sanofi, Kevzara, rheumatoid arthritis, Regeneron
Regeneron-Sanofi food allergy drug succeeds mid-stage study
Yahoo/Reuters
Mon, 10/16/17 - 09:50 am
Tags:
Regeneron, Amgen, food allergies, eosinophilic esophagitis, Dupixent
PCSK9 court saga drags on for Sanofi, Regeneron and Amgen
Biopharma Dive
Mon, 10/9/17 - 09:36 am
Tags:
Sanofi, Regeneron, Amgen, PCSK9 inhibitors, Praluent, Repatha
U.S. court reverses ban on sale of Sanofi, Regeneron drug Praluent
Yahoo/Reuters
Thu, 10/5/17 - 11:46 am
Tags:
Sanofi, Regeneron, Praluent, Repatha, patents
Sanofi and Regeneron, seeking to shield Dupixent, lose first IPR try against Amgen
Fierce Pharma
Thu, 10/5/17 - 09:34 am
Tags:
Sanofi, Regeneron, Dupixent, IPR, Amgen, patents
Sanofi and Amgen, eyeing boost for PCSK9 use, tout benefits for diabetes patients
Fierce Pharma
Mon, 09/18/17 - 11:08 am
Tags:
Sanofi, Amgen, PCSK9 inhibitors, diabetes, Regeneron, Praluent, Repatha
5 Things Regeneron's CEO Said as the Biotech Stock Sank
Motley Fool
Tue, 09/12/17 - 10:04 am
Tags:
Regeneron, Pharma CEOs, Leonard Schleifer, Sanofi, Dupixent
Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing
Xconomy
Mon, 09/11/17 - 09:33 am
Tags:
Regeneron, asthma, FDA, Sanofi, Dupixent
AbbVie preps JAK atopic dermatitis candidate for phase 3
Fierce Biotech
Sun, 09/10/17 - 11:56 am
Tags:
AbbVie, JAK inhibitors, clinical trials, atopic dermatitis, Upadacitinib, Sanofi, Regeneron, Dupixent
Sanofi, Regeneron earn ‘breakthrough’ status for a fast-track drug out to prove PD-1 dominance
Endpoints
Fri, 09/8/17 - 09:38 am
Tags:
Sanofi, Regeneron, fast track, breakthrough status, cemiplimab, anti-PD-L1

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.